Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Smart

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Trends in Neurosciences|April 23, 2013
Development of human embryonic stem cell therapies for age-related macular degenerationAmanda-Jayne F Carr, Matthew J K Smart, Conor M Ramsden, et al.
Developments in Ophthalmology|April 16, 2014
Neural retinal regeneration with pluripotent stem cellsConor M Ramsden, Michael B Powner, Amanda-Jayne F Carr, et al.
Cancer|September 1, 1978
Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinomaD E Haagensen, S J Kister, J P Vandevoorde, et al.
Shock (Augusta, Ga.)|May 23, 2008
Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shockGovindarajan Rajagopalan, Yan W Asmann, Anna K Lytle, et al.
Cancer Research|September 18, 2004
Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stressDeeDee K Smart, Karen L Ortiz, David Mattson, et al.
Cancer|February 15, 1980
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapyB V Lawrence, A Lipton, H A Harvey, et al.
Cancer|September 9, 2005
The epigenome as a molecular marker and targetDavid Gius, C Matthew Bradbury, Lunching Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2015
A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous LupusVaidehi R Chowdhary, Chao Dai, Ashenafi Y Tilahun, et al.
Cancers|August 29, 2024
MERTK Is a Potential Therapeutic Target in Ewing SarcomaSherri K Smart, Tsz Y Yeung, M Olivia Santos, et al.
Mucosal Immunology|September 26, 2013
Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cellsM Scurr, K Ladell, M Besneux, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Trends in Neurosciences|April 23, 2013
Development of human embryonic stem cell therapies for age-related macular degenerationAmanda-Jayne F Carr, Matthew J K Smart, Conor M Ramsden, et al.
Developments in Ophthalmology|April 16, 2014
Neural retinal regeneration with pluripotent stem cellsConor M Ramsden, Michael B Powner, Amanda-Jayne F Carr, et al.
Cancer|September 1, 1978
Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinomaD E Haagensen, S J Kister, J P Vandevoorde, et al.
Shock (Augusta, Ga.)|May 23, 2008
Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shockGovindarajan Rajagopalan, Yan W Asmann, Anna K Lytle, et al.
Cancer Research|September 18, 2004
Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stressDeeDee K Smart, Karen L Ortiz, David Mattson, et al.
Cancer|February 15, 1980
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapyB V Lawrence, A Lipton, H A Harvey, et al.
Cancer|September 9, 2005
The epigenome as a molecular marker and targetDavid Gius, C Matthew Bradbury, Lunching Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2015
A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous LupusVaidehi R Chowdhary, Chao Dai, Ashenafi Y Tilahun, et al.
Cancers|August 29, 2024
MERTK Is a Potential Therapeutic Target in Ewing SarcomaSherri K Smart, Tsz Y Yeung, M Olivia Santos, et al.
Mucosal Immunology|September 26, 2013
Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cellsM Scurr, K Ladell, M Besneux, et al.
Pageof 7